GlobalData (LON: DATA) forecasts FY26 margin expansion as AI transformation and platform consolidation lift contracted revenue

GlobalData PLC (LON: DATA) on January 14, 2026, announced a trading update for the fiscal year ending December 31, 2025, reporting robust forward revenue growth, AI-driven product expansion, and progress on its Growth Transformation Plan. The company also confirmed its intention to uplist from AIM to the Main Market of the London Stock Exchange, with admission scheduled for March 5, 2026.

The London-headquartered data analytics firm expects to report £322 million in FY25 revenue, representing 13 percent growth on a reported basis and 1 percent organic growth. Adjusted EBITDA is expected at approximately £110 million, reflecting a 34 percent margin, with a target to return to 40 percent margins in 2026. Contracted forward revenue grew by 6 percent, with a stronger 3 percent gain organically.

How are GlobalData’s AI investments and M&A integrations shaping its forward growth trajectory?

GlobalData’s FY25 performance reflects a transition year defined by large-scale AI enablement, product unification, and integration of six recent acquisitions. These strategic moves support its “One Platform” approach, in which proprietary data, AI tooling, and subscription-based intelligence converge to deliver cross-sector insight.

At the center of this strategy is GlobalData’s AI portfolio, including the AVA research assistant and a suite of “digital worker” tools. Unveiled during its November investor event, these AI features are designed to improve customer productivity and automate parts of the research and analytics lifecycle. Importantly, these are not mere cost-saving automations. Instead, the focus appears to be on augmenting the analyst stack with embedded, explainable AI.

CEO Mike Danson emphasized the company’s accelerated execution on transformation milestones, underlining management’s confidence that its AI-first orientation is already creating value for enterprise clients. Danson also stressed that integrating the six newly acquired businesses was a critical enabler for platform unification and cost synergy realization—two preconditions for margin expansion in 2026.

M&A integration, cost alignment, and AI deployment were not treated as sequential levers, but executed in parallel. This strategy helped GlobalData preserve renewal rate consistency across its client base, even as product offerings evolved and sales motions adapted to reflect AI inclusion.

Why does the move to the London Stock Exchange Main Market matter now?

GlobalData’s proposed March 2026 move to the Main Market signals a pivotal phase in its capital markets strategy. The AIM exit reflects both maturity in its business model and confidence in its institutional investor appeal. Main Market status will expose the company to a broader base of long-only asset managers, index inclusion opportunities, and elevated governance expectations.

Importantly, this move aligns with its ambition to re-rate the equity on the back of predictable cash flows, strong recurring revenue, and scalable margin economics. Approximately 80 percent of revenue visibility into 2026 has already been locked in, which is a key indicator for investors looking at defensible subscription-based business models.

This transparency and visibility are critical in a macro environment where investors are rewarding companies with steady renewals, robust backlog, and structural margin improvement. GlobalData’s planned uplisting reinforces its positioning as a long-duration growth story rather than a short-cycle analytics vendor.

What are the execution and margin risks in FY26 despite forward visibility?

While GlobalData has outlined a clear return path to 40 percent EBITDA margins, execution risks remain. Organic growth in FY25 was modest at 1 percent overall, despite strong reported growth from acquisitions. Segmentally, Healthcare grew 2 percent organically while Non-Healthcare remained flat. If this dynamic persists, it could limit operating leverage in the near term.

Cost synergy capture has already helped reduce margin drag, but FY26 performance will depend on cross-selling AI products to existing customers, upselling into enterprise accounts, and expanding average deal size. These tasks will require ongoing investment in customer success, product development, and go-to-market alignment—all of which could pressure short-term free cash flow.

There is also a structural question about how well customers understand and value AI-augmented research tools, particularly in non-Healthcare verticals. AVA and digital worker adoption will need to demonstrate measurable customer ROI beyond novelty to sustain pricing power and reduce churn.

The capital return framework is another consideration. In FY25, GlobalData returned over £110 million via share buybacks while also spending more than £40 million on acquisitions. With net debt at £110 million but over £200 million in available facilities, future capital deployment choices will influence market perception of balance sheet discipline.

How are investors interpreting the 2025 results and 2026 setup?

The trading update appears aligned with analyst consensus, which has priced in margin re-expansion and moderate top-line growth. However, the modest organic revenue increase may raise questions about demand elasticity, particularly in non-Healthcare verticals.

That said, institutional sentiment remains largely constructive. The company’s recurring revenue base, high renewal rates, and expanding AI monetization narrative support its repositioning as a scalable data-technology firm rather than a traditional content aggregator. Buy-side focus is expected to shift from FY25 headline growth to the operational details of FY26 execution, especially how AI and M&A integration translate to net retention uplift.

Management’s confidence in achieving a 40 percent margin level during 2026 is likely to be a key touchpoint during the March 2 earnings call, particularly with the Main Market uplisting following just three days later. Strong FY26 guidance could serve as a double trigger: validating the AI execution thesis and accelerating GlobalData’s valuation reset in the broader public equity markets.

Key takeaways on how GlobalData’s FY25 results and Main Market move could reshape its position in the UK analytics and AI sector

• GlobalData PLC expects FY25 revenue of approximately £322 million, up 13 percent on a reported basis and 1 percent organically.
• Adjusted EBITDA is forecast at £110 million with 34 percent margin, with a stated goal to re-expand to 40 percent in FY26.
• Contracted forward revenue rose 6 percent, underpinned by high renewal rates and expanding product breadth via AI offerings.
• AI tools including AVA and digital workers are central to the Growth Transformation Plan, reflecting the shift to automation-augmented analytics.
• Integration of six acquired businesses and a cost synergy program are already contributing to operating leverage gains.
• The company will submit an application to move from AIM to the London Stock Exchange Main Market on March 2, targeting admission on March 5.
• Main Market status will open access to institutional capital, enhance liquidity, and potentially enable index inclusion.
• Net debt at year-end stood at £110 million, offset by over £200 million in available facilities, giving flexibility for further investment or buybacks.
• Organic growth in non-Healthcare segments remained flat, highlighting the need for stronger AI monetization across verticals.
• GlobalData enters FY26 with approximately 80 percent visibility into analyst consensus revenue, reinforcing its long-term model stability.